Dr. Elayaraja Aruchunan started his carrier at Curtin University Malaysia in March 2008. Based on his outstanding research record, he was awarded an International Postgraduate Research Scholarship and Australian Postgraduate Award (IPRS-APA)  by the Australian Government to pursue his Ph.D. Upon his successful completion of his Ph.D. In November 2020, he began working at Universiti Malaya as a senior lecturer in the Institute of Mathematical Sciences. He has vast experience in the fields of numerical analysis, computational applied mathematics, and machine learning. Currently, he is working on developing new algorithms for solving various complex scientific, engineering, and industrial mathematical models. Over the last 12 years, he has also conducted various mathematics courses from undergraduate to postgraduate levels at higher education institutions from Malaysia and Australia.

        LING Tau Chuan is a Professor at the Universiti Malaya.  Tau Chuan graduated from the Universiti Putra Malaysia with a Degree in Biotechnology and stayed on to undertake Master Environmental Engineering study. He then completed a PhD at the University of Birmingham, UK with Prof Andrew Lyddiatt looking into development of cost-effective proteins downstream processing techniques. Following graduation in 2002, Tau Chuan joined the Universiti Putra Malaysia as a lecturer.    Since joining the Universiti Malaya, Tau Chuan has established an internationally recognised research activity in proteins downstream processing and bioprocess engineering, funded by Government of Malaysia and industries.  Tau Chuan is a Fellow of the Institution of Chemical Engineers and a Chartered Engineer. He is listed in the UM Researchers Top 2% Scientists by Stanford University and was awarded the Young Asian Biotechnologist Prize 2017 from The Society for Biotechnology, Japan. He has served as a visiting professor for several universities including Nanjing Agricultural University, Tsinghua University, Xiamen University, Lund University, National Cheng Kung University, Canterbury University and Kobe University. Tau Chuan’s expertise is in bioseparation technology and bioprocess intensification. He is internationally recognised for innovative work on the development of new and/or improved bioprocess separation and analytical techniques. He is especially well known for his work on primary capture technology, notably for inventing the technique known as aqueous two-phase systems and continuing the advancement of this and other separation techniques for large-scale application in the biopharmaceutical and nutriceutical sectors, and for his contributions to the advancement of adsorbent design and Fluidised Bed Adsorption technology. His current research mainly focuses on bioseparation, bioprocessing, green chemistry, and bioprospecting of microorganisms for useful biomolecules.        

Professor Dr FONG Choong Yi is a medical graduate from University of Nottingham, UK. He trained in Paediatrics and Paediatric Neurology in UK. His UK Paediatric Neurology specialty training include working in tertiary Neurology units at Great Ormond Street Hospital London, Evelina Children’s Hospital London and Bristol Royal Children’s Hospital. He had further subspecialty dual-fellowship training in Paediatric Epilepsy and Paediatric Electroencephalography at Brisbane, Australia (Mater & Royal Children’s Hospital Brisbane) and Melbourne, Australia (Royal Children’s Hospital Melbourne). He also is a fellow of the Royal College of Paediatrics and Child Health, UK. He is currently appointed Professor and Senior Consultant Paediatric Neurologist at University Malaya, Kuala Lumpur, Malaysia. He is head of the Paediatric Neurology division from 2014. He developed and oversees the Comprehensive Paediatric Epilepsy evaluation service in University Malaya.  He has published numerous peer-reviewed ISI publications. His research interests include paediatric epilepsy, paediatric bone health, paediatric neurology and using novel information technology applications in improving the quality of lives of children with neurological disorders. He also specialises in non-invasive and invasive epilepsy surgery assessment including long-term video-EEG monitoring, intracranial monitoring, electrocorticography and cortical stimulation. In recognition of his excellent service, he was awarded the University of Malaya excellent service award in 2016, 2019 and 2023. He was awarded the national Malaysian Society of Neuroscience Best Publication (Clinical) award in 2017 and the University of Malaya Best Clinical Neuroscience Publication award in 2019. Many of his postgraduate research students under his supervision have also won national research prizes. In 2019, he was awarded the Endeavour Executive Leadership Award by the Australian government. Professor Dr Fong plays an active role in advocation, education and forming collaborations in Child Neurology. Nationally, he is a co-author of the 2017 Malaysian Consensus Guidelines on the Management of Epilepsy, committee member of the 2019 & 2024 Malaysian Consensus Statement of Brain Death and the Malaysia National Specialist Register (NSR) Paediatric Neurology Subspecialty credentialling committee member. He is currently Vice President of Malaysian Society of Neurosciences, executive council member of Malaysian Epilepsy Council and the Malaysian Chapter of Child Neurology and Developmental Paediatrics from 2022-2026. He is a life member of the International Child Neurology Association. He was the treasurer of the Malaysian Chapter of Child Neurology & Developmental Paediatrics from 2014-2016. In the Asian region, he is a member of the Asian Epilepsy Academy (ASEPA) International League against Epilepsy and helps in running epilepsy and EEG workshops throughout the Asian region as a faculty member. He trains many overseas Paediatric Neurology fellows from the Asian region. Internationally, he is also an appointed Task Force member of the International League against Epilepsy (ILAE) on Paediatric Psychiatric Issues of the Commission of Psychiatry and on Research Advocacy of Children of the Commision on Paediatrics from 2017-2021 and 2022-2025.